Paul Schellhammer

Immunology · 2002–2010

A researcher in the Science corpus: 6 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Paul Schellhammer trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. D. Gabrilovich

Who trusts Paul Schellhammer overall

  1. K. Palucka

Papers from Paul Schellhammer's perspective

Ordered by how strongly the researchers Paul Schellhammer trusts endorse each paper. Same corpus, a different order for every researcher.

  1. A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. (Journal of the National Cancer Institute)
  2. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. (New England Journal of Medicine)
  3. Individual Comparisons by Ranking Methods
  4. Mechanisms and functional significance of tumour-induced dendritic-cell defects (Nature reviews. Immunology)
  5. Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells. (Journal of Clinical Oncology)
  6. Recent advancements in surface‐enhanced laser desorption/ionization‐time of flight‐mass spectrometry (Electrophoresis)
  7. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. (Journal of the National Cancer Institute)
  8. Immunosuppressive networks in the tumour environment and their therapeutic relevance (Nature Reviews. Cancer)
  9. Macrophage Diversity Enhances Tumor Progression and Metastasis (Cell)
  10. TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance

Their papers